nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—epilepsy syndrome	0.209	1	CbGaD
Auranofin—ALB—Oxcarbazepine—epilepsy syndrome	0.0895	0.205	CbGbCtD
Auranofin—ALB—Fosphenytoin—epilepsy syndrome	0.0782	0.179	CbGbCtD
Auranofin—ALB—Clonazepam—epilepsy syndrome	0.0708	0.162	CbGbCtD
Auranofin—ALB—Rufinamide—epilepsy syndrome	0.0577	0.132	CbGbCtD
Auranofin—ALB—Phenytoin—epilepsy syndrome	0.0504	0.116	CbGbCtD
Auranofin—ALB—Propofol—epilepsy syndrome	0.047	0.108	CbGbCtD
Auranofin—ALB—Diazepam—epilepsy syndrome	0.0426	0.0977	CbGbCtD
Auranofin—PRDX5—hindbrain—epilepsy syndrome	0.00687	0.156	CbGeAlD
Auranofin—PRDX5—brainstem—epilepsy syndrome	0.00394	0.0896	CbGeAlD
Auranofin—PRDX5—forebrain—epilepsy syndrome	0.0038	0.0865	CbGeAlD
Auranofin—PRDX5—telencephalon—epilepsy syndrome	0.00349	0.0795	CbGeAlD
Auranofin—PRDX5—medulla oblongata—epilepsy syndrome	0.00275	0.0625	CbGeAlD
Auranofin—PRDX5—midbrain—epilepsy syndrome	0.00251	0.0571	CbGeAlD
Auranofin—PRDX5—spinal cord—epilepsy syndrome	0.00245	0.0557	CbGeAlD
Auranofin—PRDX5—head—epilepsy syndrome	0.00218	0.0495	CbGeAlD
Auranofin—IKBKB—telencephalon—epilepsy syndrome	0.00207	0.0471	CbGeAlD
Auranofin—PRDX5—nervous system—epilepsy syndrome	0.00206	0.047	CbGeAlD
Auranofin—PRDX5—central nervous system—epilepsy syndrome	0.00199	0.0452	CbGeAlD
Auranofin—PRDX5—cerebellum—epilepsy syndrome	0.00194	0.0442	CbGeAlD
Auranofin—PRDX5—brain—epilepsy syndrome	0.00158	0.0359	CbGeAlD
Auranofin—IKBKB—head—epilepsy syndrome	0.00129	0.0293	CbGeAlD
Auranofin—IKBKB—nervous system—epilepsy syndrome	0.00122	0.0278	CbGeAlD
Auranofin—IKBKB—central nervous system—epilepsy syndrome	0.00118	0.0268	CbGeAlD
Auranofin—IKBKB—cerebellum—epilepsy syndrome	0.00115	0.0262	CbGeAlD
Auranofin—IKBKB—brain—epilepsy syndrome	0.000934	0.0213	CbGeAlD
Auranofin—ALB—brain—epilepsy syndrome	0.000545	0.0124	CbGeAlD
Auranofin—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000225	0.00122	CcSEcCtD
Auranofin—Dyspepsia—Diazepam—epilepsy syndrome	0.000224	0.00122	CcSEcCtD
Auranofin—Nausea—Rufinamide—epilepsy syndrome	0.000224	0.00121	CcSEcCtD
Auranofin—Rash—Lacosamide—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Auranofin—Weight decreased—Gabapentin—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Auranofin—Dermatitis—Lacosamide—epilepsy syndrome	0.000223	0.00121	CcSEcCtD
Auranofin—Eye disorder—Valproic Acid—epilepsy syndrome	0.000222	0.00121	CcSEcCtD
Auranofin—Anorexia—Clonazepam—epilepsy syndrome	0.000221	0.0012	CcSEcCtD
Auranofin—Decreased appetite—Diazepam—epilepsy syndrome	0.000221	0.0012	CcSEcCtD
Auranofin—Constipation—Vigabatrin—epilepsy syndrome	0.000221	0.0012	CcSEcCtD
Auranofin—Urticaria—Midazolam—epilepsy syndrome	0.000221	0.0012	CcSEcCtD
Auranofin—Anorexia—Phenytoin—epilepsy syndrome	0.00022	0.00119	CcSEcCtD
Auranofin—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000219	0.00119	CcSEcCtD
Auranofin—Vomiting—Clobazam—epilepsy syndrome	0.000218	0.00119	CcSEcCtD
Auranofin—Constipation—Diazepam—epilepsy syndrome	0.000218	0.00118	CcSEcCtD
Auranofin—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000217	0.00118	CcSEcCtD
Auranofin—Dyspepsia—Felbamate—epilepsy syndrome	0.000217	0.00118	CcSEcCtD
Auranofin—Rash—Clobazam—epilepsy syndrome	0.000217	0.00118	CcSEcCtD
Auranofin—Dermatitis—Clobazam—epilepsy syndrome	0.000216	0.00117	CcSEcCtD
Auranofin—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000216	0.00117	CcSEcCtD
Auranofin—Neuropathy peripheral—Gabapentin—epilepsy syndrome	0.000215	0.00117	CcSEcCtD
Auranofin—Jaundice—Gabapentin—epilepsy syndrome	0.000214	0.00116	CcSEcCtD
Auranofin—Stomatitis—Gabapentin—epilepsy syndrome	0.000214	0.00116	CcSEcCtD
Auranofin—Decreased appetite—Felbamate—epilepsy syndrome	0.000214	0.00116	CcSEcCtD
Auranofin—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000214	0.00116	CcSEcCtD
Auranofin—Dyspepsia—Zonisamide—epilepsy syndrome	0.000212	0.00115	CcSEcCtD
Auranofin—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000211	0.00115	CcSEcCtD
Auranofin—Urticaria—Fosphenytoin—epilepsy syndrome	0.000211	0.00114	CcSEcCtD
Auranofin—Constipation—Felbamate—epilepsy syndrome	0.000211	0.00114	CcSEcCtD
Auranofin—Alopecia—Valproic Acid—epilepsy syndrome	0.00021	0.00114	CcSEcCtD
Auranofin—Nausea—Lacosamide—epilepsy syndrome	0.00021	0.00114	CcSEcCtD
Auranofin—Anorexia—Carbamazepine—epilepsy syndrome	0.00021	0.00114	CcSEcCtD
Auranofin—Haematuria—Gabapentin—epilepsy syndrome	0.00021	0.00114	CcSEcCtD
Auranofin—Decreased appetite—Zonisamide—epilepsy syndrome	0.00021	0.00114	CcSEcCtD
Auranofin—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000209	0.00114	CcSEcCtD
Auranofin—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000208	0.00113	CcSEcCtD
Auranofin—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000208	0.00113	CcSEcCtD
Auranofin—Dysphagia—Topiramate—epilepsy syndrome	0.000207	0.00113	CcSEcCtD
Auranofin—Visual impairment—Pregabalin—epilepsy syndrome	0.000207	0.00113	CcSEcCtD
Auranofin—Constipation—Zonisamide—epilepsy syndrome	0.000206	0.00112	CcSEcCtD
Auranofin—Eosinophilia—Topiramate—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Auranofin—Urticaria—Vigabatrin—epilepsy syndrome	0.000205	0.00111	CcSEcCtD
Auranofin—Dyspepsia—Clonazepam—epilepsy syndrome	0.000204	0.00111	CcSEcCtD
Auranofin—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000204	0.00111	CcSEcCtD
Auranofin—Flatulence—Valproic Acid—epilepsy syndrome	0.000204	0.00111	CcSEcCtD
Auranofin—Nausea—Clobazam—epilepsy syndrome	0.000204	0.00111	CcSEcCtD
Auranofin—Dyspepsia—Phenytoin—epilepsy syndrome	0.000203	0.0011	CcSEcCtD
Auranofin—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000203	0.0011	CcSEcCtD
Auranofin—Anorexia—Lamotrigine—epilepsy syndrome	0.000203	0.0011	CcSEcCtD
Auranofin—Urticaria—Diazepam—epilepsy syndrome	0.000202	0.0011	CcSEcCtD
Auranofin—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000202	0.0011	CcSEcCtD
Auranofin—Decreased appetite—Clonazepam—epilepsy syndrome	0.000202	0.0011	CcSEcCtD
Auranofin—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Auranofin—Pruritus—Propofol—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Auranofin—Eye disorder—Pregabalin—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Auranofin—Abdominal pain—Diazepam—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Auranofin—Decreased appetite—Phenytoin—epilepsy syndrome	0.000201	0.00109	CcSEcCtD
Auranofin—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000199	0.00108	CcSEcCtD
Auranofin—Constipation—Clonazepam—epilepsy syndrome	0.000199	0.00108	CcSEcCtD
Auranofin—Constipation—Phenytoin—epilepsy syndrome	0.000197	0.00107	CcSEcCtD
Auranofin—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000197	0.00107	CcSEcCtD
Auranofin—Pancytopenia—Topiramate—epilepsy syndrome	0.000197	0.00107	CcSEcCtD
Auranofin—Pruritus—Midazolam—epilepsy syndrome	0.000197	0.00107	CcSEcCtD
Auranofin—Constipation—Oxcarbazepine—epilepsy syndrome	0.000196	0.00107	CcSEcCtD
Auranofin—Urticaria—Felbamate—epilepsy syndrome	0.000196	0.00106	CcSEcCtD
Auranofin—Abdominal pain—Felbamate—epilepsy syndrome	0.000195	0.00106	CcSEcCtD
Auranofin—Vomiting—Acetazolamide—epilepsy syndrome	0.000195	0.00106	CcSEcCtD
Auranofin—Diarrhoea—Propofol—epilepsy syndrome	0.000195	0.00106	CcSEcCtD
Auranofin—Pruritus—Levetiracetam—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Auranofin—Neutropenia—Topiramate—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Auranofin—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000194	0.00105	CcSEcCtD
Auranofin—Anaemia—Valproic Acid—epilepsy syndrome	0.000192	0.00104	CcSEcCtD
Auranofin—Urticaria—Zonisamide—epilepsy syndrome	0.000191	0.00104	CcSEcCtD
Auranofin—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000191	0.00104	CcSEcCtD
Auranofin—Abdominal pain—Zonisamide—epilepsy syndrome	0.000191	0.00103	CcSEcCtD
Auranofin—Visual impairment—Gabapentin—epilepsy syndrome	0.00019	0.00103	CcSEcCtD
Auranofin—Alopecia—Pregabalin—epilepsy syndrome	0.00019	0.00103	CcSEcCtD
Auranofin—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.00019	0.00103	CcSEcCtD
Auranofin—Angioedema—Valproic Acid—epilepsy syndrome	0.000189	0.00103	CcSEcCtD
Auranofin—Constipation—Carbamazepine—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Auranofin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Auranofin—Weight decreased—Topiramate—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Auranofin—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Auranofin—Pruritus—Fosphenytoin—epilepsy syndrome	0.000188	0.00102	CcSEcCtD
Auranofin—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000187	0.00102	CcSEcCtD
Auranofin—Leukopenia—Valproic Acid—epilepsy syndrome	0.000185	0.00101	CcSEcCtD
Auranofin—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000185	0.001	CcSEcCtD
Auranofin—Flatulence—Pregabalin—epilepsy syndrome	0.000185	0.001	CcSEcCtD
Auranofin—Urticaria—Clonazepam—epilepsy syndrome	0.000185	0.001	CcSEcCtD
Auranofin—Eye disorder—Gabapentin—epilepsy syndrome	0.000184	0.001	CcSEcCtD
Auranofin—Abdominal pain—Clonazepam—epilepsy syndrome	0.000184	0.000997	CcSEcCtD
Auranofin—Dysgeusia—Pregabalin—epilepsy syndrome	0.000183	0.000996	CcSEcCtD
Auranofin—Urticaria—Phenytoin—epilepsy syndrome	0.000183	0.000995	CcSEcCtD
Auranofin—Pruritus—Vigabatrin—epilepsy syndrome	0.000183	0.000992	CcSEcCtD
Auranofin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000182	0.00099	CcSEcCtD
Auranofin—Constipation—Lamotrigine—epilepsy syndrome	0.000182	0.000988	CcSEcCtD
Auranofin—Nausea—Acetazolamide—epilepsy syndrome	0.000182	0.000987	CcSEcCtD
Auranofin—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000181	0.000985	CcSEcCtD
Auranofin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000181	0.000985	CcSEcCtD
Auranofin—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000181	0.000984	CcSEcCtD
Auranofin—Vomiting—Propofol—epilepsy syndrome	0.000181	0.000981	CcSEcCtD
Auranofin—Stomatitis—Topiramate—epilepsy syndrome	0.00018	0.000979	CcSEcCtD
Auranofin—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.00018	0.000978	CcSEcCtD
Auranofin—Pruritus—Diazepam—epilepsy syndrome	0.00018	0.000977	CcSEcCtD
Auranofin—Conjunctivitis—Topiramate—epilepsy syndrome	0.00018	0.000976	CcSEcCtD
Auranofin—Rash—Propofol—epilepsy syndrome	0.000179	0.000973	CcSEcCtD
Auranofin—Dermatitis—Propofol—epilepsy syndrome	0.000179	0.000972	CcSEcCtD
Auranofin—Vomiting—Midazolam—epilepsy syndrome	0.000177	0.00096	CcSEcCtD
Auranofin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000177	0.00096	CcSEcCtD
Auranofin—Haematuria—Topiramate—epilepsy syndrome	0.000176	0.000957	CcSEcCtD
Auranofin—Rash—Midazolam—epilepsy syndrome	0.000175	0.000952	CcSEcCtD
Auranofin—Dermatitis—Midazolam—epilepsy syndrome	0.000175	0.000951	CcSEcCtD
Auranofin—Urticaria—Carbamazepine—epilepsy syndrome	0.000175	0.00095	CcSEcCtD
Auranofin—Vomiting—Levetiracetam—epilepsy syndrome	0.000175	0.000948	CcSEcCtD
Auranofin—Alopecia—Gabapentin—epilepsy syndrome	0.000174	0.000947	CcSEcCtD
Auranofin—Pruritus—Felbamate—epilepsy syndrome	0.000174	0.000946	CcSEcCtD
Auranofin—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000174	0.000945	CcSEcCtD
Auranofin—Diarrhoea—Diazepam—epilepsy syndrome	0.000174	0.000945	CcSEcCtD
Auranofin—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000174	0.000945	CcSEcCtD
Auranofin—Rash—Levetiracetam—epilepsy syndrome	0.000173	0.00094	CcSEcCtD
Auranofin—Anaemia—Pregabalin—epilepsy syndrome	0.000173	0.00094	CcSEcCtD
Auranofin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000173	0.000939	CcSEcCtD
Auranofin—Agranulocytosis—Topiramate—epilepsy syndrome	0.000173	0.000937	CcSEcCtD
Auranofin—Angioedema—Pregabalin—epilepsy syndrome	0.000171	0.000929	CcSEcCtD
Auranofin—Pruritus—Zonisamide—epilepsy syndrome	0.000171	0.000926	CcSEcCtD
Auranofin—Flatulence—Gabapentin—epilepsy syndrome	0.000169	0.000919	CcSEcCtD
Auranofin—Urticaria—Lamotrigine—epilepsy syndrome	0.000169	0.000918	CcSEcCtD
Auranofin—Nausea—Propofol—epilepsy syndrome	0.000169	0.000917	CcSEcCtD
Auranofin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000169	0.000915	CcSEcCtD
Auranofin—Diarrhoea—Felbamate—epilepsy syndrome	0.000168	0.000914	CcSEcCtD
Auranofin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000168	0.000913	CcSEcCtD
Auranofin—Dysgeusia—Gabapentin—epilepsy syndrome	0.000168	0.000913	CcSEcCtD
Auranofin—Leukopenia—Pregabalin—epilepsy syndrome	0.000168	0.00091	CcSEcCtD
Auranofin—Rash—Fosphenytoin—epilepsy syndrome	0.000167	0.000907	CcSEcCtD
Auranofin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000167	0.000906	CcSEcCtD
Auranofin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000166	0.000899	CcSEcCtD
Auranofin—Nausea—Midazolam—epilepsy syndrome	0.000165	0.000897	CcSEcCtD
Auranofin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000165	0.000895	CcSEcCtD
Auranofin—Pruritus—Clonazepam—epilepsy syndrome	0.000164	0.000892	CcSEcCtD
Auranofin—Vomiting—Vigabatrin—epilepsy syndrome	0.000164	0.000892	CcSEcCtD
Auranofin—Pruritus—Phenytoin—epilepsy syndrome	0.000163	0.000886	CcSEcCtD
Auranofin—Nausea—Levetiracetam—epilepsy syndrome	0.000163	0.000886	CcSEcCtD
Auranofin—Rash—Vigabatrin—epilepsy syndrome	0.000163	0.000884	CcSEcCtD
Auranofin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000163	0.000884	CcSEcCtD
Auranofin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000162	0.000881	CcSEcCtD
Auranofin—Vomiting—Diazepam—epilepsy syndrome	0.000162	0.000878	CcSEcCtD
Auranofin—Anorexia—Valproic Acid—epilepsy syndrome	0.000161	0.000875	CcSEcCtD
Auranofin—Rash—Diazepam—epilepsy syndrome	0.00016	0.000871	CcSEcCtD
Auranofin—Dermatitis—Diazepam—epilepsy syndrome	0.00016	0.00087	CcSEcCtD
Auranofin—Visual impairment—Topiramate—epilepsy syndrome	0.00016	0.000869	CcSEcCtD
Auranofin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000159	0.000863	CcSEcCtD
Auranofin—Anaemia—Gabapentin—epilepsy syndrome	0.000159	0.000862	CcSEcCtD
Auranofin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000158	0.000857	CcSEcCtD
Auranofin—Nausea—Fosphenytoin—epilepsy syndrome	0.000157	0.000855	CcSEcCtD
Auranofin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000157	0.000852	CcSEcCtD
Auranofin—Angioedema—Gabapentin—epilepsy syndrome	0.000157	0.000852	CcSEcCtD
Auranofin—Vomiting—Felbamate—epilepsy syndrome	0.000157	0.00085	CcSEcCtD
Auranofin—Pruritus—Carbamazepine—epilepsy syndrome	0.000156	0.000846	CcSEcCtD
Auranofin—Rash—Felbamate—epilepsy syndrome	0.000155	0.000843	CcSEcCtD
Auranofin—Eye disorder—Topiramate—epilepsy syndrome	0.000155	0.000842	CcSEcCtD
Auranofin—Dermatitis—Felbamate—epilepsy syndrome	0.000155	0.000842	CcSEcCtD
Auranofin—Leukopenia—Gabapentin—epilepsy syndrome	0.000154	0.000835	CcSEcCtD
Auranofin—Nausea—Vigabatrin—epilepsy syndrome	0.000153	0.000833	CcSEcCtD
Auranofin—Vomiting—Zonisamide—epilepsy syndrome	0.000153	0.000832	CcSEcCtD
Auranofin—Rash—Zonisamide—epilepsy syndrome	0.000152	0.000825	CcSEcCtD
Auranofin—Dermatitis—Zonisamide—epilepsy syndrome	0.000152	0.000824	CcSEcCtD
Auranofin—Nausea—Diazepam—epilepsy syndrome	0.000151	0.00082	CcSEcCtD
Auranofin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000151	0.000818	CcSEcCtD
Auranofin—Pruritus—Lamotrigine—epilepsy syndrome	0.000151	0.000817	CcSEcCtD
Auranofin—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.00015	0.000813	CcSEcCtD
Auranofin—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000149	0.000808	CcSEcCtD
Auranofin—Vomiting—Clonazepam—epilepsy syndrome	0.000148	0.000802	CcSEcCtD
Auranofin—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000147	0.000798	CcSEcCtD
Auranofin—Alopecia—Topiramate—epilepsy syndrome	0.000147	0.000796	CcSEcCtD
Auranofin—Vomiting—Phenytoin—epilepsy syndrome	0.000147	0.000796	CcSEcCtD
Auranofin—Rash—Clonazepam—epilepsy syndrome	0.000146	0.000795	CcSEcCtD
Auranofin—Dermatitis—Clonazepam—epilepsy syndrome	0.000146	0.000794	CcSEcCtD
Auranofin—Nausea—Felbamate—epilepsy syndrome	0.000146	0.000794	CcSEcCtD
Auranofin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000146	0.000792	CcSEcCtD
Auranofin—Anorexia—Pregabalin—epilepsy syndrome	0.000146	0.000791	CcSEcCtD
Auranofin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000146	0.00079	CcSEcCtD
Auranofin—Rash—Phenytoin—epilepsy syndrome	0.000145	0.00079	CcSEcCtD
Auranofin—Dermatitis—Phenytoin—epilepsy syndrome	0.000145	0.000789	CcSEcCtD
Auranofin—Rash—Oxcarbazepine—epilepsy syndrome	0.000145	0.000785	CcSEcCtD
Auranofin—Constipation—Valproic Acid—epilepsy syndrome	0.000145	0.000785	CcSEcCtD
Auranofin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000145	0.000785	CcSEcCtD
Auranofin—Nausea—Zonisamide—epilepsy syndrome	0.000143	0.000777	CcSEcCtD
Auranofin—Flatulence—Topiramate—epilepsy syndrome	0.000142	0.000773	CcSEcCtD
Auranofin—Dysgeusia—Topiramate—epilepsy syndrome	0.000142	0.000768	CcSEcCtD
Auranofin—Vomiting—Carbamazepine—epilepsy syndrome	0.00014	0.00076	CcSEcCtD
Auranofin—Rash—Carbamazepine—epilepsy syndrome	0.000139	0.000754	CcSEcCtD
Auranofin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000139	0.000753	CcSEcCtD
Auranofin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000138	0.000751	CcSEcCtD
Auranofin—Nausea—Clonazepam—epilepsy syndrome	0.000138	0.000749	CcSEcCtD
Auranofin—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000137	0.000745	CcSEcCtD
Auranofin—Nausea—Phenytoin—epilepsy syndrome	0.000137	0.000744	CcSEcCtD
Auranofin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000136	0.00074	CcSEcCtD
Auranofin—Vomiting—Lamotrigine—epilepsy syndrome	0.000135	0.000735	CcSEcCtD
Auranofin—Urticaria—Valproic Acid—epilepsy syndrome	0.000134	0.000729	CcSEcCtD
Auranofin—Rash—Lamotrigine—epilepsy syndrome	0.000134	0.000728	CcSEcCtD
Auranofin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000134	0.000728	CcSEcCtD
Auranofin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000134	0.000726	CcSEcCtD
Auranofin—Anorexia—Gabapentin—epilepsy syndrome	0.000134	0.000725	CcSEcCtD
Auranofin—Anaemia—Topiramate—epilepsy syndrome	0.000134	0.000725	CcSEcCtD
Auranofin—Decreased appetite—Pregabalin—epilepsy syndrome	0.000133	0.000721	CcSEcCtD
Auranofin—Nausea—Carbamazepine—epilepsy syndrome	0.000131	0.00071	CcSEcCtD
Auranofin—Constipation—Pregabalin—epilepsy syndrome	0.000131	0.00071	CcSEcCtD
Auranofin—Leukopenia—Topiramate—epilepsy syndrome	0.000129	0.000702	CcSEcCtD
Auranofin—Nausea—Lamotrigine—epilepsy syndrome	0.000126	0.000686	CcSEcCtD
Auranofin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000125	0.000679	CcSEcCtD
Auranofin—Dyspepsia—Gabapentin—epilepsy syndrome	0.000123	0.00067	CcSEcCtD
Auranofin—Decreased appetite—Gabapentin—epilepsy syndrome	0.000122	0.000662	CcSEcCtD
Auranofin—Urticaria—Pregabalin—epilepsy syndrome	0.000121	0.000659	CcSEcCtD
Auranofin—Abdominal pain—Pregabalin—epilepsy syndrome	0.000121	0.000656	CcSEcCtD
Auranofin—Constipation—Gabapentin—epilepsy syndrome	0.00012	0.000651	CcSEcCtD
Auranofin—Pruritus—Valproic Acid—epilepsy syndrome	0.00012	0.00065	CcSEcCtD
Auranofin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000116	0.000628	CcSEcCtD
Auranofin—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000115	0.000627	CcSEcCtD
Auranofin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000115	0.000622	CcSEcCtD
Auranofin—Anorexia—Topiramate—epilepsy syndrome	0.000112	0.00061	CcSEcCtD
Auranofin—Urticaria—Gabapentin—epilepsy syndrome	0.000111	0.000605	CcSEcCtD
Auranofin—Abdominal pain—Gabapentin—epilepsy syndrome	0.000111	0.000602	CcSEcCtD
Auranofin—Pruritus—Pregabalin—epilepsy syndrome	0.000108	0.000587	CcSEcCtD
Auranofin—Vomiting—Valproic Acid—epilepsy syndrome	0.000108	0.000584	CcSEcCtD
Auranofin—Rash—Valproic Acid—epilepsy syndrome	0.000107	0.000579	CcSEcCtD
Auranofin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000107	0.000578	CcSEcCtD
Auranofin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000105	0.000568	CcSEcCtD
Auranofin—Dyspepsia—Topiramate—epilepsy syndrome	0.000104	0.000564	CcSEcCtD
Auranofin—Decreased appetite—Topiramate—epilepsy syndrome	0.000103	0.000557	CcSEcCtD
Auranofin—Constipation—Topiramate—epilepsy syndrome	0.000101	0.000548	CcSEcCtD
Auranofin—Nausea—Valproic Acid—epilepsy syndrome	0.0001	0.000545	CcSEcCtD
Auranofin—Pruritus—Gabapentin—epilepsy syndrome	9.92e-05	0.000538	CcSEcCtD
Auranofin—Vomiting—Pregabalin—epilepsy syndrome	9.72e-05	0.000528	CcSEcCtD
Auranofin—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.65e-05	0.000524	CcSEcCtD
Auranofin—Rash—Pregabalin—epilepsy syndrome	9.64e-05	0.000523	CcSEcCtD
Auranofin—Dermatitis—Pregabalin—epilepsy syndrome	9.63e-05	0.000523	CcSEcCtD
Auranofin—Diarrhoea—Gabapentin—epilepsy syndrome	9.59e-05	0.000521	CcSEcCtD
Auranofin—Urticaria—Topiramate—epilepsy syndrome	9.37e-05	0.000509	CcSEcCtD
Auranofin—Abdominal pain—Topiramate—epilepsy syndrome	9.32e-05	0.000506	CcSEcCtD
Auranofin—Nausea—Pregabalin—epilepsy syndrome	9.08e-05	0.000493	CcSEcCtD
Auranofin—Vomiting—Gabapentin—epilepsy syndrome	8.91e-05	0.000484	CcSEcCtD
Auranofin—Rash—Gabapentin—epilepsy syndrome	8.84e-05	0.00048	CcSEcCtD
Auranofin—Dermatitis—Gabapentin—epilepsy syndrome	8.83e-05	0.000479	CcSEcCtD
Auranofin—Pruritus—Topiramate—epilepsy syndrome	8.35e-05	0.000453	CcSEcCtD
Auranofin—Nausea—Gabapentin—epilepsy syndrome	8.33e-05	0.000452	CcSEcCtD
Auranofin—Diarrhoea—Topiramate—epilepsy syndrome	8.07e-05	0.000438	CcSEcCtD
Auranofin—Vomiting—Topiramate—epilepsy syndrome	7.5e-05	0.000407	CcSEcCtD
Auranofin—Rash—Topiramate—epilepsy syndrome	7.44e-05	0.000404	CcSEcCtD
Auranofin—Dermatitis—Topiramate—epilepsy syndrome	7.43e-05	0.000403	CcSEcCtD
Auranofin—Nausea—Topiramate—epilepsy syndrome	7.01e-05	0.00038	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.84e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.83e-05	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism—GAMT—epilepsy syndrome	2.83e-05	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism—PNPO—epilepsy syndrome	2.83e-05	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism—EPM2A—epilepsy syndrome	2.83e-05	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.83e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK10—epilepsy syndrome	2.82e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SOCS3—epilepsy syndrome	2.82e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDC42—epilepsy syndrome	2.81e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PARK2—epilepsy syndrome	2.77e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RELA—epilepsy syndrome	2.75e-05	0.000218	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PPIA—epilepsy syndrome	2.75e-05	0.000218	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.74e-05	0.000217	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.74e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—epilepsy syndrome	2.72e-05	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RELA—epilepsy syndrome	2.71e-05	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR3—epilepsy syndrome	2.68e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MTOR—epilepsy syndrome	2.66e-05	0.00021	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA4—epilepsy syndrome	2.63e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Metabolism—QDPR—epilepsy syndrome	2.63e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.63e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ST3GAL3—epilepsy syndrome	2.62e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FYN—epilepsy syndrome	2.6e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MEF2C—epilepsy syndrome	2.59e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPY2R—epilepsy syndrome	2.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR8—epilepsy syndrome	2.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR1—epilepsy syndrome	2.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR9—epilepsy syndrome	2.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM3—epilepsy syndrome	2.52e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM4—epilepsy syndrome	2.52e-05	0.0002	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.51e-05	0.000199	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FYN—epilepsy syndrome	2.5e-05	0.000198	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—epilepsy syndrome	2.49e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DUSP4—epilepsy syndrome	2.47e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SSTR2—epilepsy syndrome	2.47e-05	0.000196	CbGpPWpGaD
Auranofin—ALB—Metabolism—COX3—epilepsy syndrome	2.47e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ACTB—epilepsy syndrome	2.46e-05	0.000195	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—epilepsy syndrome	2.44e-05	0.000194	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.44e-05	0.000193	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.44e-05	0.000193	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.41e-05	0.000191	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—YWHAZ—epilepsy syndrome	2.4e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM8—epilepsy syndrome	2.39e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PGF—epilepsy syndrome	2.39e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—epilepsy syndrome	2.36e-05	0.000187	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.35e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.34e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—KCNB1—epilepsy syndrome	2.34e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—PFKL—epilepsy syndrome	2.34e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.34e-05	0.000186	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.34e-05	0.000186	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—epilepsy syndrome	2.29e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.29e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAO1—epilepsy syndrome	2.28e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OPRD1—epilepsy syndrome	2.28e-05	0.00018	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.27e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—epilepsy syndrome	2.24e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TSC2—epilepsy syndrome	2.24e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTK2B—epilepsy syndrome	2.24e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP1—epilepsy syndrome	2.24e-05	0.000177	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.23e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR7—epilepsy syndrome	2.18e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDYN—epilepsy syndrome	2.18e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CHRM1—epilepsy syndrome	2.18e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM1—epilepsy syndrome	2.18e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CCR2—epilepsy syndrome	2.18e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.18e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1RN—epilepsy syndrome	2.17e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Immune System—DUSP6—epilepsy syndrome	2.16e-05	0.000171	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—TSC2—epilepsy syndrome	2.15e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ADRA2A—epilepsy syndrome	2.15e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Metabolism—NEU1—epilepsy syndrome	2.14e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Metabolism—UPB1—epilepsy syndrome	2.14e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Metabolism—ATIC—epilepsy syndrome	2.14e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAT—epilepsy syndrome	2.14e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SRC—epilepsy syndrome	2.13e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—epilepsy syndrome	2.1e-05	0.000167	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD17B4—epilepsy syndrome	2.06e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6ST—epilepsy syndrome	2.06e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GFAP—epilepsy syndrome	2.05e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAL—epilepsy syndrome	2.05e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—epilepsy syndrome	2.03e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CHRM3—epilepsy syndrome	2.03e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM5—epilepsy syndrome	2.03e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP2—epilepsy syndrome	2.03e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—epilepsy syndrome	2.02e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40—epilepsy syndrome	2.02e-05	0.00016	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS1—epilepsy syndrome	2.01e-05	0.000159	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.99e-05	0.000158	CbGpPWpGaD
Auranofin—ALB—Metabolism—GBE1—epilepsy syndrome	1.99e-05	0.000158	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PRKCB—epilepsy syndrome	1.98e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CX3CR1—epilepsy syndrome	1.95e-05	0.000154	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.95e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—epilepsy syndrome	1.94e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BDKRB1—epilepsy syndrome	1.91e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CX3CL1—epilepsy syndrome	1.91e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CHRM2—epilepsy syndrome	1.91e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HBEGF—epilepsy syndrome	1.9e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FOS—epilepsy syndrome	1.88e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT3—epilepsy syndrome	1.88e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Metabolism—ASAH1—epilepsy syndrome	1.87e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT3—epilepsy syndrome	1.87e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.86e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GABBR1—epilepsy syndrome	1.86e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.85e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—epilepsy syndrome	1.84e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Metabolism—STXBP1—epilepsy syndrome	1.82e-05	0.000144	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—epilepsy syndrome	1.8e-05	0.000142	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRH3—epilepsy syndrome	1.78e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Metabolism—NT5E—epilepsy syndrome	1.77e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALAD—epilepsy syndrome	1.77e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.76e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OPRM1—epilepsy syndrome	1.75e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Immune System—S100B—epilepsy syndrome	1.72e-05	0.000137	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CDC42—epilepsy syndrome	1.72e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SOCS3—epilepsy syndrome	1.71e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDC42—epilepsy syndrome	1.7e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.69e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.69e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGF2—epilepsy syndrome	1.66e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.66e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR3—epilepsy syndrome	1.65e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADSL—epilepsy syndrome	1.62e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPY—epilepsy syndrome	1.61e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ATP2A2—epilepsy syndrome	1.61e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGF2—epilepsy syndrome	1.6e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLUL—epilepsy syndrome	1.59e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—epilepsy syndrome	1.58e-05	0.000125	CbGpPWpGaD
Auranofin—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.56e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HSPB1—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CRH—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL2—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OXT—epilepsy syndrome	1.56e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RELA—epilepsy syndrome	1.54e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FYN—epilepsy syndrome	1.53e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FYN—epilepsy syndrome	1.52e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—epilepsy syndrome	1.51e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MEF2C—epilepsy syndrome	1.51e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RELA—epilepsy syndrome	1.48e-05	0.000118	CbGpPWpGaD
Auranofin—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.47e-05	0.000116	CbGpPWpGaD
Auranofin—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.46e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Immune System—YWHAZ—epilepsy syndrome	1.46e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—epilepsy syndrome	1.45e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.45e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC1—epilepsy syndrome	1.45e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTK2B—epilepsy syndrome	1.45e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.44e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Metabolism—AQP1—epilepsy syndrome	1.42e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SST—epilepsy syndrome	1.41e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR2—epilepsy syndrome	1.41e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTRK2—epilepsy syndrome	1.41e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DUSP6—epilepsy syndrome	1.39e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.39e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.38e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRA2A—epilepsy syndrome	1.38e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLAT—epilepsy syndrome	1.37e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.36e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—epilepsy syndrome	1.35e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.35e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL12—epilepsy syndrome	1.32e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BDKRB2—epilepsy syndrome	1.32e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—epilepsy syndrome	1.32e-05	0.000105	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—epilepsy syndrome	1.3e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TSC2—epilepsy syndrome	1.3e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—epilepsy syndrome	1.3e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR1—epilepsy syndrome	1.3e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUNB—epilepsy syndrome	1.3e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLCB1—epilepsy syndrome	1.29e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.28e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—CHRM3—epilepsy syndrome	1.28e-05	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR7—epilepsy syndrome	1.27e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HBEGF—epilepsy syndrome	1.23e-05	9.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—epilepsy syndrome	1.21e-05	9.62e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.21e-05	9.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT3—epilepsy syndrome	1.21e-05	9.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCB—epilepsy syndrome	1.2e-05	9.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6ST—epilepsy syndrome	1.2e-05	9.5e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—epilepsy syndrome	1.2e-05	9.5e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.19e-05	9.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADAM10—epilepsy syndrome	1.18e-05	9.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.17e-05	9.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—epilepsy syndrome	1.17e-05	9.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—S100B—epilepsy syndrome	1.11e-05	8.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS3—epilepsy syndrome	1.1e-05	8.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDC42—epilepsy syndrome	1.1e-05	8.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOS—epilepsy syndrome	1.1e-05	8.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—epilepsy syndrome	1.07e-05	8.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AVP—epilepsy syndrome	1.07e-05	8.45e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG2—epilepsy syndrome	1.05e-05	8.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.02e-05	8.08e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.01e-05	8.03e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—epilepsy syndrome	1.01e-05	7.99e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.01e-05	7.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FYN—epilepsy syndrome	9.8e-06	7.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—H2AFX—epilepsy syndrome	9.77e-06	7.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MEF2C—epilepsy syndrome	9.75e-06	7.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF2—epilepsy syndrome	9.69e-06	7.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—YWHAZ—epilepsy syndrome	9.42e-06	7.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGF—epilepsy syndrome	9.32e-06	7.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—epilepsy syndrome	9.2e-06	7.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2D6—epilepsy syndrome	9.14e-06	7.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—epilepsy syndrome	9.07e-06	7.18e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RELA—epilepsy syndrome	9e-06	7.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2A—epilepsy syndrome	8.87e-06	7.03e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—epilepsy syndrome	8.82e-06	6.99e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADRA2A—epilepsy syndrome	8.7e-06	6.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—epilepsy syndrome	8.67e-06	6.87e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	8.59e-06	6.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC2—epilepsy syndrome	8.43e-06	6.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGT—epilepsy syndrome	8.42e-06	6.67e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A1—epilepsy syndrome	8.27e-06	6.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—epilepsy syndrome	8.25e-06	6.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLCB1—epilepsy syndrome	8.18e-06	6.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—TH—epilepsy syndrome	8.15e-06	6.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—epilepsy syndrome	8.13e-06	6.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—epilepsy syndrome	8.08e-06	6.4e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.02e-06	6.36e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—epilepsy syndrome	7.88e-06	6.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCB—epilepsy syndrome	7.78e-06	6.16e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6ST—epilepsy syndrome	7.75e-06	6.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—epilepsy syndrome	7.54e-06	5.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—epilepsy syndrome	7.24e-06	5.74e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—epilepsy syndrome	7.13e-06	5.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—epilepsy syndrome	7.08e-06	5.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—epilepsy syndrome	7.07e-06	5.6e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.94e-06	5.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—epilepsy syndrome	6.93e-06	5.49e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—epilepsy syndrome	6.8e-06	5.39e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAT—epilepsy syndrome	6.71e-06	5.32e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—epilepsy syndrome	6.53e-06	5.17e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF2—epilepsy syndrome	6.27e-06	4.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—epilepsy syndrome	6.07e-06	4.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RELA—epilepsy syndrome	5.82e-06	4.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—epilepsy syndrome	5.7e-06	4.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGT—epilepsy syndrome	5.32e-06	4.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—epilepsy syndrome	5.25e-06	4.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—epilepsy syndrome	5.21e-06	4.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—epilepsy syndrome	5.1e-06	4.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—epilepsy syndrome	4.96e-06	3.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—epilepsy syndrome	4.57e-06	3.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—epilepsy syndrome	4.48e-06	3.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—epilepsy syndrome	4.45e-06	3.53e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—epilepsy syndrome	4.43e-06	3.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—epilepsy syndrome	4.39e-06	3.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—epilepsy syndrome	3.57e-06	2.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—epilepsy syndrome	2.84e-06	2.25e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—epilepsy syndrome	1.8e-06	1.42e-05	CbGpPWpGaD
